Literature DB >> 21109704

Emergency management of minor head injury in anticoagulated patients.

A Leiblich1, S Mason.   

Abstract

Approximately 1% of the UK population receives anticoagulation with warfarin. Head injury accounts for some 1.4 million emergency department attendances in the country. Therefore, significant numbers of patients with head injury have a therapeutic coagulopathy. This review aims to examine the existing evidence for optimal management of warfarinised head injured patients, particularly with respect to the need for early CT imaging and the use of reversal agents in cases of proved haemorrhage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21109704     DOI: 10.1136/emj.2009.079442

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  4 in total

1.  Intracranial hemorrhage in anticoagulated patients with mild traumatic brain injury: significant differences between direct oral anticoagulants and vitamin K antagonists.

Authors:  Alessandro Cipriano; Alessio Pecori; Alessandra Eugenia Bionda; Michele Bardini; Francesca Frassi; Francesco Leoli; Valentina Lami; Lorenzo Ghiadoni; Massimo Santini
Journal:  Intern Emerg Med       Date:  2018-03-08       Impact factor: 3.397

2.  "Early Trigger" Intravenous Vitamin K: Optimizing Target-Driven Care in Warfarinised Patients With Hip Fracture.

Authors:  Marina Diament; Kirsty MacLeod; Jonathan O'Hare; Anne Tate; Will Eardley
Journal:  Geriatr Orthop Surg Rehabil       Date:  2015-12

3.  Should all anticoagulated patients with head injury receive a CT scan? Decision-analysis modelling of an observational cohort.

Authors:  Maxine Kuczawski; Matt Stevenson; Steve Goodacre; M Dawn Teare; Shammi Ramlakhan; Francis Morris; Suzanne Mason
Journal:  BMJ Open       Date:  2016-12-13       Impact factor: 2.692

4.  AHEAD Study: an observational study of the management of anticoagulated patients who suffer head injury.

Authors:  Suzanne Mason; Maxine Kuczawski; M Dawn Teare; Matt Stevenson; Steve Goodacre; Shammi Ramlakhan; Francis Morris; Joanne Rothwell
Journal:  BMJ Open       Date:  2017-01-13       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.